MIDTERM RESULTS OF THE OBSERVATIONAL NON-INTERVENTIONAL CLINICAL STUDY "EVALUATION OF THE EFFECTIVENESS OF THE CARNITINE OROTATE AND BIPHENYLDIMETHYLDICARBOXYLATE COMPLEX IN THE PATHOGENETIC THERAPY OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE: A PROSPEC
1 2025
Изменен: 28.02.2025Путь: Главная / Публикации
MIDTERM RESULTS OF THE OBSERVATIONAL NON-INTERVENTIONAL CLINICAL STUDY "EVALUATION OF THE EFFECTIVENESS OF THE CARNITINE OROTATE AND BIPHENYL DIMETHYL DICARBOXYLATE COMPLEX IN THE PATHOGENETIC THERAPY OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE: A PROSP
11172 8556 11173 11174 3262 3256 8555 9442 11175 10030 11176 11177 11178 11179 11180 8271 11181 11182 11183 1 2025
Изменен: 28.02.2025Путь: Главная / Басты бет / Жарияланымдар
MIDTERM RESULTS OF THE OBSERVATIONAL NON-INTERVENTIONAL CLINICAL STUDY "EVALUATION OF THE EFFECTIVENESS OF THE CARNITINE OROTATE AND BIPHENYL DIMETHYL DICARBOXYLATE COMPLEX IN THE PATHOGENETIC THERAPY OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE: A PROSP
11172 8556 11173 11174 3262 3256 8555 9442 11175 10030 11176 11177 11178 11179 11180 8271 11181 11182 11183 1 2025 10.34689/SH.2025.27.1.001 Introduction. Metabolic dysfunction-associated fatty liver disease (MAFLD) is a widespread pathology requiring effective treatment approaches. One promising direction is the use of a complex of carnitine orotate and biphenyl dimethyl dicarboxylate (COC and BDD), which ...
Изменен: 28.02.2025Путь: Главная / Home / Publications
Результаты поиска 1 - 3 из 3
Начало | Пред. | 1 | След. | Конец
Отсортировано по релевантности | Сортировать по дате